The review of Treatments for Pulmonary Sarcoidosis (Paramothayan S, Lasserson T. Respir
Med 2008; 102: 1e9) is important because it emphasizes to the internal medicine community
the meagerness of evidence for significant long-term benefit of any medicine for sarcoidosis.
Also, all medicines used have siginificant side effects. This increases the possible
importance of environmentally based measures for ameliorating sarcoidosis. In the authors'
suggestions for future directions of research, my suggested contribution should be included …